OMICRON (B.1.1.529): A new SARS-CoV-2 variant of concern mounting worldwide fear

被引：221

作者：

Thakur, Vikram ^{[1
,2
]}

Ratho, Radha Kanta ^{[2
]}

机构：

[1] Govt Med Coll, Viral Res Diagnost Lab VRDL, Patiala 147001, Punjab, India

[2] Post Grad Inst Med Educ & Res PGIMER, Dept Virol, Chandigarh 160012, India

来源：

JOURNAL OF MEDICAL VIROLOGY | 2022年 / 94卷 / 05期

关键词：

OMICRON; re-infection; spike protein; transmission; travel restrictions; vaccines;

D O I：

10.1002/jmv.27541

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Recent emergence of the SARS-CoV-2 variant as OMICRON has become a global concern. This short note highlights the identification and global spread of OMICRON which has spread over 77 nations by now, which resulted in many hypotheses about its origin and degree of infectivity. The detection of mutations in the RBD region of Spike protein is a concern by surpassing vaccine immunity. The ahead will speak about its transmission potentiality, infectivity, disease morbidity as well as its effect on COVID-19 vaccines.

引用

页码：1821 / 1824

页数：4

共 50 条

[31] COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a at the end of the tunnel?
Mattiuzzi, Camilla
Henry, Brandon M.
Lippi, Giuseppe
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 118 : 167 - 168
[32] Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions
Islam, Fahadul
Dhawan, Manish
Nafady, Mohamed H.
Emran, Talha Bin
Mitra, Saikat
Choudhary, Om Prakash
Akter, Aklima
ANNALS OF MEDICINE AND SURGERY, 2022, 78
[33] Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
Dejnirattisai, Wanwisa
Shaw, Robert H.
Supasa, Piyada
Liu, Chang
Stuart, Arabella S. V.
Pollard, Andrew J.
Liu, Xinxue
Lambe, Teresa
Crook, Derrick
Stuart, Dave I.
Mongkolsapaya, Juthathip
Nguyen-Van-Tam, Jonathan S.
Snape, Matthew D.
Screaton, Gavin R.
LANCET, 2022, 399 (10321): : 234 - 236
[34] Detecting SARS-CoV-2 Omicron B.1.1.529 Variant in Wastewater Samples by Using Nanopore Sequencing
Rasmussen, Lasse D.
Richter, Stine R.
Midgley, Sofie E.
Franck, Kristina T.
EMERGING INFECTIOUS DISEASES, 2022, 28 (06) : 1296 - 1298
[35] A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)
Lu, Yuying
Li, Qianlin
Fan, Huahao
Liao, Conghui
Zhang, Jingsong
Hu, Huan
Yi, Huaimin
Peng, Yuanli
Lu, Jiahai
Chen, Zeliang
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 353 - 367
[36] Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study
Sheward, Daniel J.
Kim, Changil
Ehling, Roy A.
Pankow, Alec
Dopico, Xaquin Castro
Dyrdak, Robert
Martin, Darren P.
Reddy, Sai T.
Dillner, Joakim
Hedestam, Gunilla B. Karlsson
Albert, Jan
Murrell, Ben
LANCET INFECTIOUS DISEASES, 2022, 22 (06): : 813 - 820
[37] Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant
Ren, Wenlin
Zhang, Yu
Rao, Juhong
Wang, Ziyi
Lan, Jun
Liu, Kunpeng
Zhang, Xuekai
Hu, Xue
Yang, Chen
Zhong, Guocai
Zhang, Rong
Wang, Xinquan
Shan, Chao
Ding, Qiang
MBIO, 2023, 14 (02):
[38] Characteristics of the SARS-CoV-2 Omicron (B.1.1.529) Variant and Emerging Impact on Global Public Health
Islam, Md Rabiul
Nasreen, Waheeda
Anjum, Ramisa
Shahriar, Mohammad
Roy, Arpita
Dhama, Kuldeep
Bhuiyan, Mohiuddin Ahmed
CLINICAL PATHOLOGY, 2022, 15
[39] Fractional order mathematical model for B.1.1.529 SARS-Cov-2 Omicron variant with quarantine and vaccination
S. Dickson
S. Padmasekaran
Pushpendra Kumar
International Journal of Dynamics and Control, 2023, 11 : 2215 - 2231
[40] A Novel Probiotic-Based Oral Vaccine against SARS-CoV-2 Omicron Variant B.1.1.529
Chau, Eddie Chung Ting
Kwong, Tsz Ching
Pang, Chun Keung
Chan, Lee Tung
Chan, Andrew Man Lok
Yao, Xiaoqiang
Tam, John Siu Lun
Chan, Shun Wan
Leung, George Pak Heng
Tai, William Chi Shing
Kwan, Yiu Wa
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)

← 1 2 3 4 5 →